Clinical end point acceptance limit [Study As­sess­ment]

posted by PKS – India, 2019-04-05 08:45  – Posting: # 20125
Views: 1,199

Should I conclude bio-equivalence with the values of [-0.2025, 0.076] in clinical end point study. Can I assume it as within the interval of (-0.20, 0.20)

Edit: Category changed; see also this post #1. Please follow the Forum’s Policy[Helmut]

Complete thread:

 Admin contact
20,138 posts in 4,246 threads, 1,386 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time (Europe/Vienna): 18:03 CET

It is better to debate a question without settling it
than to settle a question without debating it.    Joseph Joubert

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz